420 related articles for article (PubMed ID: 28238669)
41. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
42. Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1.
Inose Y; Izumi Y; Takada-Takatori Y; Akaike A; Koyama Y; Kaneko S; Kume T
Neurosci Lett; 2020 Sep; 736():135268. PubMed ID: 32712353
[TBL] [Abstract][Full Text] [Related]
43. Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease.
Morroni F; Sita G; Tarozzi A; Cantelli-Forti G; Hrelia P
Brain Res; 2014 Nov; 1589():93-104. PubMed ID: 25257035
[TBL] [Abstract][Full Text] [Related]
44. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
[TBL] [Abstract][Full Text] [Related]
45. Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage.
Liu X; Shao R; Li M; Yang G
Cell Biochem Biophys; 2014 Nov; 70(2):1247-54. PubMed ID: 24948472
[TBL] [Abstract][Full Text] [Related]
46. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
47. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes.
Hseu YC; Chou CW; Senthil Kumar KJ; Fu KT; Wang HM; Hsu LS; Kuo YH; Wu CR; Chen SC; Yang HL
Food Chem Toxicol; 2012 May; 50(5):1245-55. PubMed ID: 22386815
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotection by scorpion venom heat resistant peptide in 6-hydroxydopamine rat model of early-stage Parkinson's disease.
Yin SM; Zhao D; Yu DQ; Li SL; An D; Peng Y; Xu H; Sun YP; Wang DM; Zhao J; Zhang WQ
Sheng Li Xue Bao; 2014 Dec; 66(6):658-66. PubMed ID: 25516514
[TBL] [Abstract][Full Text] [Related]
49. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
Pan X; Chen C; Huang J; Wei H; Fan Q
Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
[TBL] [Abstract][Full Text] [Related]
50. Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway.
Huang TT; Hao DL; Wu BN; Mao LL; Zhang J
Biochem Biophys Res Commun; 2017 Dec; 493(4):1443-1449. PubMed ID: 28986252
[TBL] [Abstract][Full Text] [Related]
51. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.
Xue YQ; Zhao LR; Guo WP; Duan WM
Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174
[TBL] [Abstract][Full Text] [Related]
52. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
Jin F; Wu Q; Lu YF; Gong QH; Shi JS
Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
[TBL] [Abstract][Full Text] [Related]
53. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.
Baluchnejadmojarad T; Roghani M; Mafakheri M
Neurosci Lett; 2010 Aug; 480(3):206-10. PubMed ID: 20600617
[TBL] [Abstract][Full Text] [Related]
54. Humulus japonicus Prevents Dopaminergic Neuron Death in 6-Hydroxydopamine-Induced Models of Parkinson's Disease.
Ryu YK; Kang Y; Go J; Park HY; Noh JR; Kim YH; Hwang JH; Choi DH; Han SS; Oh WK; Lee CH; Kim KS
J Med Food; 2017 Feb; 20(2):116-123. PubMed ID: 28146406
[TBL] [Abstract][Full Text] [Related]
55. Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA.
Javid H; Rahimian R; Salimi M; Haghani-Samani E; Farhadi M; Torkaman-Boutorabi A
Mol Biol Rep; 2024 Jun; 51(1):768. PubMed ID: 38884894
[TBL] [Abstract][Full Text] [Related]
56. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
57. Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
Roghani M; Behzadi G
Brain Res; 2001 Feb; 892(1):211-7. PubMed ID: 11172767
[TBL] [Abstract][Full Text] [Related]
58. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.
Han B; Hu J; Shen J; Gao Y; Lu Y; Wang T
Eur J Pharmacol; 2013 Aug; 714(1-3):83-8. PubMed ID: 23791614
[TBL] [Abstract][Full Text] [Related]
59. Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.
Manouchehrabadi M; Farhadi M; Azizi Z; Torkaman-Boutorabi A
Neurotox Res; 2020 Jan; 37(1):156-170. PubMed ID: 31364033
[TBL] [Abstract][Full Text] [Related]
60. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
